We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple scleros... MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Show more
Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an Aggregate of $14 Million Up Front MyMD Pharmaceuticals, Inc.ยฎ (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -7.28155339806 | 2.06 | 2.06 | 1.8 | 294409 | 1.93904697 | CS |
4 | -1.08 | -36.1204013378 | 2.99 | 3.03 | 1.8 | 116505 | 2.02310812 | CS |
12 | -1.59 | -45.4285714286 | 3.5 | 3.5 | 1.8 | 263677 | 2.54028123 | CS |
26 | -6.634 | -77.6451310861 | 8.544 | 10.665 | 1.8 | 871206 | 6.0468233 | CS |
52 | -52.39 | -96.4825046041 | 54.3 | 63.9 | 1.8 | 775206 | 15.42936166 | CS |
156 | -122.29 | -98.46215781 | 124.2 | 298.5 | 1.8 | 418141 | 51.47468416 | CS |
260 | -160.99 | -98.8275015347 | 162.9 | 298.5 | 1.8 | 427139 | 57.19333312 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions